Abstract. At the University of Michigan the dermatologic surgeon works closely with the head and neck surgeon in resecting extensive cutaneous malignancies that could benefit from the combined skills of both surgical specialists. Mohs surgery offers complete microscopic controlled resection of the cutaneous portion of skin cancers. Tumors extending deeply from the skin into underlying bone and soft tissue are resected with the assistance of the head and neck surgeon familiar with the anatomy and trained in the protection of the vital structures of the head and neck. It is evident that patients with large or aggressive basal cell carcinomas will best be served when this interdisciplinary approach has become commonplace.
ARTICLE
perform craniofacial resections of tumors extending to regions of the anterior skull base. Likewise, neurotologists have teamed up with neurosurgeons to resect extensive posterior and middle cranial fossa tumors, which overall has resulted in improved function postoperatively. It is only logical that the Mohs surgeon seek the skills of the head and neck surgeon to assist him in resecting extensive facial skin cancers that extend into the nasal passage, paranasal sinuses, or orbital region.' Such extension may require the assistance of a head and neck surgeon to adequately remove the neoplasm extending into the deeper planes of the face and neck. Similarly, extensive facial skin cancers may invade deeply to involve the cranium and occasionally the underlying dura mater and brain. Such cases call for the assistance of surgeons trained in neurosurgery.
At the University of Michigan the dermatologic surgeon works closely with the head and neck surgeon in resecting extensive cutaneous malignancies that could benefit from combining the skills of both surgical specialists.2 Tumors requiring this multidisciplinary approach are those demonstrating aggressive biologic behavior. Such tumors frequently occur in the "H" zone of the face (Fig. 1 ). This zone is noted for its high incidence of recalcitrant basal cell carcinomas (BCCs), and includes the central midfacial area including the upper lip, nose, and medial canthal regions. The zone extends horizontally to incorporate the lower eyelids extending to the preauricular area. The vertical portion of the "H' shaped zone of the facial skin is a large area of skin in the preauricular area extending superiorly into the temple and inferiorly toward the angle of the mandible. This area also includes portions of 1095 BCC OF HEAD AND NECK f FIGURE 1. The "H"shaped zone of the face is noted for its high incidence of recalcitrant BCCs.
the auricle and postauricular skin. The "H" zone represents a region where BCC tends to be more invasive and destructive and to recur more freq~e n t l y .~ Thus, it is more difficult to treat skin cancer in this region compared with similar tumors located in other sites about the face and neck.
The apparent major reason for the aggressiveness of skin cancers in the "H" zone is related to the fact that this region represents an area rich in embryologic fusion planes. Fusion planes are frequently perpendicular to the surface of facial skin and provide tissue interfaces for extension of tumor deeply toward underlying structures of the face. 4 When this occurs, it is best for the dermatologic surgeon to seek the assistance of a head and neck surgeon to facilitate resecting tumor involving bone, muscle, and vital structures.
During the last 5 years, we have had extensive experience treating large facial skin malignancies by the interdisciplinary approach combining the skills of the dermatologic surgeon and the head and neck surgeon. The interdisciplinary approach allows for complete microscopic controlled excision of the tumor while maximizing conservation of tissue, and thus minimizing functional and cosmetic disability. The indications and techniques for the use of Mohs surgery in the treatment of skin cancer have been d e~c r i b e d .~
The purpose of this paper is to present representative cases that exemplify the usefulness 1096 of combining the surgical skills of these two surgical specialists.
AURICULAR REGION
In contrast to morpheaform BCCs that extend widely in a peripheral fashion, ulcerative BCCs tend to grow more deeply into the underlying structures of the face. BCCs occurring in the preauricular area are frequently of the ulcerative type and have a relatively high recurrence rate due to the tendency of the tumor to extend medially along the perichondrium of the external auditory canal.5 Robins6 reports the preauricular area as having statistically significantly higher recurrence rates following controlled microscopic excision of BCC compared with other anatomic regions of the face. The aggressive nature of BCC involving the preauricular area is represented by the patient in Figure 2. This patient presented with a neglected ulcerative BCC of the preauricular skin. Figure 2 also demonstrates the skin defect following adequate removal of the tumor from the skin of the preauricular region. However, tumor extended medially in the subperichondrial plane of the cartilaginous external auditory canal toward the bony canal. Tumor extended beyond the confines of the canal anteriorly and necessitated a parotidectomy with preservation of the facial nerve. Extension of tumor with removal of the cartilaginous and bony external medially toward the tympanic membrane required auditory canal. In such instances, the surgical apremoval of the entire condyle of the mandible and proach is accomplished by making a standard tymtympanic bone down to, but not including, the panomeatal flap and elevating the skin of the exbony anulus.
ternal canal away from the anulus. Following skin Extensive BCCs extending into the auditory elevation, the most medial aspect of the flap is samcanal sometimes require radical mastoidectomy pled by the dermatologic surgeon to evaluate the BCC OF HEAD AND NECK FIGURE 3A AND B. Following Mohs excision of BCC of the preauricular area necessitating removal of the left parotid gland and sacrifice of the facial nerve. medial surgical margin. Should tumor be noted at the extreme medial aspect of the flap, it is recommended that the patient undergo removal of the tympanic membrane, annular ligament, and radical mastoidectomy. At the time of tympanic membrane removal, the mucous membrane in the middle ear medial and adjacent t o the anulus is sampled and examined for foci BCC. If the presence of tumor is documented in the middle ear, consideration must be given to a formal temporal bone resection or the utilization of postoperative radiotherapy. Patients with BCC extending deeply from the preauricular area requiring removal of the external ear canal should probably be observed from 12 to 18 months by surfacing the area with a split-thickness skin graft rather than subjecting them to immediate reconstruction using a local or regional flap. This is particularly true if there is concern for the adequacy of surgical margins around the neoplasm. The thin covering offered by the skin graft may permit early detection of recurrent neoplasm (Fig. 2) . Figure 3 represents a patient that developed BCC of the preauricular area necessitating removal of the left parotid gland and sacrifice of the facial nerve. Tumor extended onto the zygomatic arch, and sampling of the periosteum by the dermatologic surgeon demonstrated tumor involvement. Tumor was noted to extend to the deep aspect of the zygomatic arch. Working with the assistance of the dermatologic surgeon who provided histologic assessment of the surgical margins, the head and neck surgeon removed the entire arch as well as the upper portion of the masseter muscle. It was the consensus of the surgeons involved that surgical margins were adequate to allow immediate reconstruction of the defect. The defect was reconstructed utilizing a cervical flap based inferiorly and harvested from the postauricular area.
A postauricular cervical cutaneous flap is advantageous for reconstruction of defects in the preauricular area because it provides the best color and texture match with that of the skin of the remaining cheek and forehead regions (Fig. 3) . Another advantage is that the secondary defect, although often requiring a split-thickness skin graft to facilitate closure, is located in the postauricular area which is helpful for scar camouflage and overall cosmesis.
Whenever it is necessary to sacrifice the facial nerve in order to completely remove a BCC, attempts should be made to graft the portion of resected nerve. However, frequently tumors located in the preauricular area extend peripherally to such a degree that the distal branches of the facial nerve have to be sacrificed in order to ablate all of the tumor. Such instances preclude any attempt to reanimate the face by cable nerve grafting. Unfortunately, in most of these cases, there is a frequent need to remove the masseter muscle and portions of the temporalis muscle, thus precluding the possibility of rehabilitating the face with a dynamic sling. The only alternative in such cases may be the use of static fascia lata slings to suspend the oral commissure in a more symmetrical position.
Similar to BCCs arising in the preauricular skin, tumors occurring in the postauricular sulcus often grow in an aggressive manner extending through the concha1 cartilage as well as spreading into the external auditory canal. However, tumor spread
Dermatol. Surg. Oncol. 1390 October 1987
tends to be more in a superior and inferior direct i~n .~ Tumor may spread inferiorly to involve the sternocleidomastoid muscle and deeper structures of the upper neck or spread medially to involve the cortex of the mastoid bone. Ceilley et al.7 reported a higher than usual recurrence rate in treating auricular BCCs and noted the frequent aggressiveness of tumors occurring in the postauricular region.
Ulcerative tumors located in the inferior aspect of the postauricular sulcus often extend inferiorly to involve the sternocleidomastoid muscle, tail of the parotid gland, and deeper structures of the neck.5 A representative case is shown in Figure 4 . The patient presented with a recurrent ulcerative BCC of the lower postauricular sulcus that extended into the deep structures of the upper neck, necessitating a regional neck dissection confined to the upper posterior cervical triangle in order to irradicate the entire tumor. In patients requiring parotidectomy or regional neck dissection, the head and neck surgeon performing the operation has relied on the dermatologic surgeon to assist him in surveying all of the deep soft tissue margins, thus ensuring that all tumor has been eradicated from the deeper tissue planes of the neck. In this instance, the tail of the parotid gland, posterior digastric muscle, and upper sternocleidomastoid muscle were all histologically examined to ensure adequacy of tumor ablation in tissue planes deep to the skin (Fig. 4) .
Along with location of BCCs, tumor histology plays an important role in the treatment of these cutaneous neoplasms. The more common tumor histologies (noduloulcerative, superficial) represent little problem in the diagnosis and treatment, particularly if the tumor is small and occurs outside of the "H' zone of the face. Those tumors with aggressive histologic behavior, however, often warrant a more exacting treatment of microscopic controlled resection. These histologic subgroups include the morpheaform or sclerotic BCC, multicentric infiltrating tumor, and the aggressive keratinizing BCC (basosquamous carcinoma or metatypical carcinoma).
A higher than usual recurrence rate for morpheaform BCC, even after treatment by Mohs technique, has been reported. This may result from subtle subclinical extension and possibly from stromal dependence of this tumor. Salasche and Amonettes found subclinical extensions to average 7.2 mm in 51 morpheaform BCCs. They noted that the greatest degree of subclinical extension occurred in the preauricular region. Ceilley et al. 7 found that of their inadequately excised BCCs of the ear, the morpheaform type was the most common. as a large portion of the scalp located in the occipital area. This case nicely demonstrates the massive subclinical extension that can occur with morpheaform BCCs. It also demonstrates the usefulness of an interdisciplinary approach for the management FIGURE 5B. Defect following Mohs excision.
of extensive cutaneous malignancies. The dermatologic surgeon can ensure adequacy of resection margins and the head and neck surgeon can provide technical assistance in resection of deep tissues and reconstruction of the ablative defect following ablative surgery. Figure 6 demonstrates another patient suffering from a histologically aggressive tumor. The neoplasm presented as a keratotic (basosquamous) BCC located in the postauricular area with extension into the parotid gland. The patient required a radical parotidectomy and sacrifice of the facial nerve and facial nerve cable grafting. Because of the aggressiveness of the tumor, it was elected to administer postoperative radiotherapy, although all surgical margins were free of residual tumor.
The decision to combine postoperative radiotherapy with microscopically controlled surgical excision of extensive skin cancers is a matter of clinical judgment based on the size and location of tumor and the histology of the cancer. We have treated a small select group of patients suffering from BCC with postoperative radiation therapy in specific instances where recurrent tumor required extensive resection of the facial soft tissues and where surgical margins of normal tissue were not as abundant as we would desire. More specifically, postoperative radiotherapy has been used to treat potentially persistent microscopic disease in cases where cancer encroached on regions of the skull (Fig. 7) . In addition to removal of the lateral aspect of the nose, a portion or all of the premaxilla may require removal. Such resections are facilitated by the cooperative efforts of the dermatologic surgeon and the head and neck surgeon. Nasal passage and paranasal sinus involvement with facial skin cancer occurs not only as a result of neglected or recurrent BCC, but when tumors are biologically aggressive and are located in the midfacial region. Reconstruction after controlled microscopic surgical ablation of such neoplasms should be delayed 12 to 18 months in most instances to provide an opportunity for any persistent carcinoma to manifest itself. In the interim, the surgical defect can be covered with a split-thickness skin graft. A prosthesis can be manufactured to assist in the cosmetic and functional rehabilitation of the patient, and can be used until reconstruction is deemed advisable.
BCC occurring in the superior portions of the midface occur most frequently in the region of the medial canthus. Tumors located near the medial canthus of the eye may extend deeply into the orbit or the anterior ethmoid sinuses, necessitating resection of part or of all of the orbital contents and ethmoidectomy . At the time of complete microscopic excision, tumor was noted to involve the periosteum of the nasal bones and the lamina papyracia bilaterally. An interdisciplinary approach combining the skills of the dermatologic surgeon and the head and neck surgeon provided the best opportunity for complete eradication of disease by removing the nasal bones and the lamina papyracia bilaterally along with the upper portion of the nasal septum. The extensiveness of the tumor and the history of recurrent disease called for delay of the reconstruction for a period of 18 months to provide ease in observing the region for possible persistent tumor. Indeed, the patient developed a recurrence in the skin adjacent to the nasal defect 1 year after our attempt to cure him of his tumor.
1.
Tumors occurring in the midfacial skin may track along the infraorbital nerve to involve the maxillary sinus or orbit and may extend as far posteriorly as the foramen rotundum. An example of this is seen in Figure 9 , which demonstrates a surgical specimen consisting of the maxilla and contents of the orbit. Orbital exenteration was necessary because a recurrent BCC of the facial skin had extended along the infraorbital nerve into the maxillary antrum and orbit regions. Tumor invaded the orbital fat and ex-]. Dermatol. Surg. Oncol. 13: lO October 1987 traocular muscles to such a degree that it was not possible to preserve the ophthalmic globe. Tumor also tracked along the infraorbital nerve posteriorly toward the foramen rotundum. Following maxillectomy, frozen section analysis of the nerve exiting the foramen demonstrated malignant cells. Thus it was elected to treat the patient with postoperative radiotherapy. Unfortunately, the patient developed recurrent disease at the skull base and eventually died of his cancer.
This case exemplifies the need for appropriate radiographic studies preoperatively in instances where the clinician is concerned about deep extension of tumor toward the paranasal sinuses. It is also a good example of the aggressiveness manifested by some BCCs occurring in the midfacial region and the need on occasion to use radiation therapy as an adjunct to surgical excision of extensive skin cancers.
SCALP
BCCs of the scalp tend to occur most commonly in the temple area and may extend deeply to involve the underlying periosteum, temporalis muscle, and calvarium. Extensive tumors may require removal of a large portion of the scalp overlying the frontal and parietal bones. The underlying periosteum is frequently involved with neoplasm necessitating removal, thus making reconstruction of such defects more difficult. In instances where periosteum is involved with tumor but no gross tumor is noted to involve the calvarium, the bone is treated by surgical removal of the exterior portion utilizing a rotating cutting burr. It is difficult for a skin graft to heal on bare bone and it may take many months for the defect to granulate and heal by second intention. This is true in spite of drilling holes through the outer cortical bone to facilitate the growth of granulation tissue from the more vascular medullary portion of the calvarium.
Large areas of exposed bone are best treated by rotating a local scalp flap to cover the exposed bone." The scalp flap is elevated in a plane superficial to the periosteum so that the secondary defect can be closed with a split-thickness skin graft if necessary, or on occasion, may be closed primarily by local advancement of surrounding scalp tissue. Primary closure is aided by performing incisions through the galea parallel to the major vascular supply to the scalp to enhance stretching of the flap.
Large neglected ulcerative BCCs of the scalp not infrequently invade the underlying calvarium. Tumors that grossly invade the outer cortex of the calvarium require wide full-thickness resection of the cranium. When bone involvement is suspected by the clinician, the patient should be evaluated preoperatively with appropriate radiographic studies including polytomography or CAT scan analysis to assess the cranial bone and underlying brain. Extensive involvement with BCC of cranial bone necessitates well-conceived preoperative planning by the surgical disciplines involved with treating such patients.
Frequently, the dermatologic surgeon will seek the assistance of the head and neck surgeon and the neurosurgeon in resecting such tumors. The multidisciplinary team must be prepared to trace the tumor as deep as necessary in order to eradicate all neoplasm. This may require multiple frozen sections to assess the parameter of the scalp defect, as well as the surgical margins of the dura mater and occasionally the brain itself. The dermatologic surgeon has the capability of processing bone within 24 hours so that bony margins can be readily assessed for the possibility of tumor involvement. When a bony margin is found to contain tumor, the patient is returned to the operating room the next day for additional bone removal.
An example of the interdisciplinary approach for the treatment of large tumors of the scalp is represented in Figure 10 . The skills of the dermatologic surgeon and the head and neck surgeon were combined with those of a neurosurgeon to completely eradicate a neglected BCC involving the postauricular scalp. Tumor extended into the mastoid cortex necessitating a modified radical mastoidectomy, removing all of the cortex of the mastoid bone. Fortunately, tumor did not extend into the air cells of the mastoid and thus the facial nerve and hearing were spared. Tumor also extended full thickness through the posterior calvarium and into the underlying dura mater in the vicinity of the lateral sinus.
Tumor invasion of the dura mater over the sinus necessitated removal of the sinus, as well as a large area of dura mater. Complete microscopic survey of the deep surface of the resected dura mater demonstrated no evidence of penetration of tumor into the underlying brain. The defect in the dura mater was repaired with a fascia lata graft and the dural BAKER ET AL FIGURE 10A. BCC of occipital scalp. graft and surrounding exposed calvarium were covered with a medially based shoulder flap.
This case highlights the importance of combining the skills of various surgical disciplines to maximize the opportunity of eradicating extensive facial skin malignancies that involve the head and neck region while at the same time providing for the reconstruction of the resulting defect, thus limiting functional impairment.
CONCLUSION
The usefulness of an interdisciplinary approach combining the skills of the dermatologic surgeon and the head and neck surgeon for the management of extensive BCCs of the head and neck is well founded in our experience. The Mohs surgical technique offers meticulous marginal control for a variety of cutaneous, as well as paracutaneous neoplasms, with the advantage of conserving normal surrounding tissues and structures. Tumor extending deeply from the skin into underlying bone and soft tissue is resected with the assistance of a head and neck surgeon familiar with the anatomy and trained in the protection of the vital structures of the head and neck. The skills of the neurosurgeon are necessary when cancer invades or encroaches upon the central nervous system. It is evident that patients with large or aggressive BCCs will best be served when this interdisciplinary approach has become commonplace. Five patients with chromomycosis of the legs from the S5o Paulo area, Brazil, after unsuccessful attempts of treatment with amphotericin B, 5-fluorocitosine, and ketoconazole, were successfully treated by several applications of liquid nitrogen, with healing accompanied by cicatricization. The evolution of the disease had been from 1 to 25 years. Four patients had verrucous patches and one patient a sarcoid-like lesion. All patients were culture positive for Fonseca pedrosi. There has been no recurrence during a 2 to 4 year follow-up. Effective therapy for advanced stage mycosis fungoides (MF) is lacking. The authors report their results in 8 patients treated with a combination of bleomycin, cyclophosphamide, and prednisolone and in 12 patients who were treated with these three drugs plus either etretinate (11 patients) or 13-cis-retinoic acid (1 patient). All 20 patients had tumor stage MF, and 14 patients had extracutaneous disease. Of the 8 patients receiving combination chemotherapy, 5 showed a partial or complete remission, with a median remission of 3 months. In the patients treated with retinoids, 7 showed a partial or complete response lasting a median of 6 months. The side effects observed were those anticipated and these were usually controlled by a reduction in the dosage of the offending drug. Although this study suggests that retinoids might be beneficial in the management of MF, more patients need to be studied and long-term follow-up is essential (only 1 patient was treated for a year or longer). Photodynamic therapy (PDT) to manage cancer has recently received much attention. One major drawback, however, is that the photosensitizing agents used make the patient extremely photosensitive. In order to circumvent this problem, the authors studied the effect of the argon laser on cultured human squamous cell carcinoma cells (SCC) which had been incubated with non-toxic doses of Rhodamine-123 (Rh-123). Rh-123 is a mitrochondrial specific dye which is non-photosensitizing and has a peak absorption at 511 nm. The authors found that when SCC cells were incubated with Rh-123 there was an enhancement of the tumoricidal effect of the argon laser. How useful this methodology will be when applied to the clinical situation, however, remains to be demonstrated. Erycette TRADEMARK (erythromycin 2%)
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